معرفی
Klaus Lovendahl is a Research Scientist affiliated with the Department of Medicinal Chemistry at the University of Washington School of Pharmacy. He is associated with the Lee Lab, where he contributes to advanced research in molecular biology and virology. His work spans structural analysis of viral proteins, CRISPR-based genetic techniques, and comparative genomics.
His research interests include the structural and functional analysis of viral proteins such as SARS-CoV-2 spike and HIV Env, CRISPR-Cas9 optimization for homology-directed repair, Notch signaling mechanisms, and comparative genomics of bacterial strains like Shewanella. These areas intersect with molecular biology, virology, and biotechnology.
Recent publications highlight his focus on SARS-CoV-2 and HIV structural biology, covalent protein-DNA linkages, and systems biology of Shewanella. He has contributed to understanding viral entry mechanisms, improving gene-editing efficiency, and exploring bacterial genomic diversity.
Klaus collaborates with interdisciplinary teams including the Lee Lab, leveraging mass spectrometry and cryo-electron tomography resources at the School of Pharmacy. His expertise aligns with the University of Washington's emphasis on translational research in medicinal chemistry and virology.
